Ovarian Cancer Pipeline Review Sponsors Plan Frontline Punch Smart Combinations
Ovarian Cancer Pipeline Review: Sponsors Plan Frontline Punch, Smart Combinations
01:16 EST 7 Dec 2018 |
SCRIP
Combination studies of drugs for ovarian cancer have heavy focus on PARP, PD-1/L1 and VEGF mechanisms.
More From BioPortfolio on "Ovarian Cancer Pipeline Review: Sponsors Plan Frontline Punch, Smart Combinations"